Huber M - Search Results

1

Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.

Grunow R, Porsch-Ozcürümez M, Splettstoesser W, Buckendahl A, Hahn U, Beyer W, Böhm R, Huber M, vd Esche U, Bessler W, Frangoulidis D, Finke EJ. Grunow R, et al. Among authors: huber m. Vaccine. 2007 May 4;25(18):3679-83. doi: 10.1016/j.vaccine.2007.01.056. Epub 2007 Jan 23. Vaccine. 2007. PMID: 17287051

2

Passive vaccination with a human monoclonal antibody: generation of antibodies and studies for efficacy in Bacillus anthracis infections.

vor dem Esche U, Huber M, Zgaga-Griesz A, Grunow R, Beyer W, Hahn U, Bessler WG. vor dem Esche U, et al. Among authors: huber m. Immunobiology. 2011 Jul;216(7):847-53. doi: 10.1016/j.imbio.2010.12.001. Epub 2010 Dec 10. Immunobiology. 2011. PMID: 21397977

3

Generation of mouse polyclonal and human monoclonal antibodies against Bacillus anthracis toxin.

Huber M, Vor Dem Esche U, Grunow R, Bessler WG. Huber M, et al. Drugs Exp Clin Res. 2005;31(2):35-43. Drugs Exp Clin Res. 2005. PMID: 15929604

4

Bacterial cell wall components as immunomodulators--II. The bacterial cell wall extract OM-85 BV as unspecific activator, immunogen and adjuvant in mice.

Bessler WG, Huber M, Baier W. Bessler WG, et al. Among authors: huber m. Int J Immunopharmacol. 1997 Sep-Oct;19(9-10):551-8. doi: 10.1016/s0192-0561(97)00055-6. Int J Immunopharmacol. 1997. PMID: 9637353

5

Lipopeptides: adjuvanticity in conventional and genetic immunization.

Mittenbühler K, v d Esche U, Heinevetter L, Bessler WG, Huber M. Mittenbühler K, et al. Among authors: huber m. FEMS Immunol Med Microbiol. 2003 Jul 15;37(2-3):193-200. doi: 10.1016/S0928-8244(03)00069-5. FEMS Immunol Med Microbiol. 2003. PMID: 12832125 Free article.

6

Immunogenicity of an E. coli extract after oral or intraperitoneal administration: induction of antibodies against pathogenic bacterial strains.

Huber M, Baier W, Serr A, Bessler WG. Huber M, et al. Int J Immunopharmacol. 2000 Jan;22(1):57-68. doi: 10.1016/s0192-0561(99)00064-8. Int J Immunopharmacol. 2000. PMID: 10684989

7

Immunomodulating effects of OM-89, a bacterial extract from Escherichia coli, in murine and human leukocytes.

Bessler WG, Puce K, vor dem Esche U, Kirschning C, Huber M. Bessler WG, et al. Among authors: huber m. Arzneimittelforschung. 2009;59(11):571-7. doi: 10.1055/s-0031-1296446. Arzneimittelforschung. 2009. PMID: 20066966

8

Th1-orientated immunological properties of the bacterial extract OM-85-BV.

Huber M, Mossmann H, Bessler WG. Huber M, et al. Eur J Med Res. 2005 May 20;10(5):209-17. Eur J Med Res. 2005. PMID: 15946922

9

Modulation of the Th1/Th2 bias by lipopeptide and saponin adjuvants in orally immunized mice.

Huber M, Baier W, Bessler WG, Heinevetter L. Huber M, et al. Immunobiology. 2002 Mar;205(1):61-73. doi: 10.1078/0171-2985-00111. Immunobiology. 2002. PMID: 11999345

10

Immunostimulation by bacterial components: I. Activation Of macrophages and enhancement of genetic immunization by the lipopeptide P3CSK4.

vd Esche U, Ayoub M, Pfannes SD, Müller MR, Huber M, Wiesmüller KH, Loop T, Humar M, Fischbach KF, Strünkelnberg M, Hoffmann P, Bessler WG, Mittenbühler K. vd Esche U, et al. Among authors: huber m. Int J Immunopharmacol. 2000 Dec;22(12):1093-102. doi: 10.1016/s0192-0561(00)00069-2. Int J Immunopharmacol. 2000. PMID: 11137616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,056 results

Search Page